PH25317A - FUSED THIENO-, PYRAZOLO- or FURANS-TETRAHYDROAMINO-QUINOLINOLS, AMINOTETRAHYDROBENZONAPHTHYRIDINES, THEIR USE AS MEDICAMENTS - Google Patents

FUSED THIENO-, PYRAZOLO- or FURANS-TETRAHYDROAMINO-QUINOLINOLS, AMINOTETRAHYDROBENZONAPHTHYRIDINES, THEIR USE AS MEDICAMENTS

Info

Publication number
PH25317A
PH25317A PH36107A PH36107A PH25317A PH 25317 A PH25317 A PH 25317A PH 36107 A PH36107 A PH 36107A PH 36107 A PH36107 A PH 36107A PH 25317 A PH25317 A PH 25317A
Authority
PH
Philippines
Prior art keywords
tetrahydroamino
aminotetrahydrobenzonaphthyridines
quinolinols
furans
pyrazolo
Prior art date
Application number
PH36107A
Other languages
English (en)
Inventor
Gregory Michael Shutske
Kevin J Kapples
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of PH25317A publication Critical patent/PH25317A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH36107A 1986-11-24 1987-11-23 FUSED THIENO-, PYRAZOLO- or FURANS-TETRAHYDROAMINO-QUINOLINOLS, AMINOTETRAHYDROBENZONAPHTHYRIDINES, THEIR USE AS MEDICAMENTS PH25317A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/934,038 US4753950A (en) 1986-11-24 1986-11-24 Fused heterocyclic tetrahydroaminoquinolinols and related compounds

Publications (1)

Publication Number Publication Date
PH25317A true PH25317A (en) 1991-04-30

Family

ID=25464855

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36107A PH25317A (en) 1986-11-24 1987-11-23 FUSED THIENO-, PYRAZOLO- or FURANS-TETRAHYDROAMINO-QUINOLINOLS, AMINOTETRAHYDROBENZONAPHTHYRIDINES, THEIR USE AS MEDICAMENTS

Country Status (17)

Country Link
US (1) US4753950A (no)
EP (1) EP0273176B1 (no)
JP (1) JPS63141980A (no)
KR (1) KR880006203A (no)
AT (1) ATE77625T1 (no)
AU (1) AU604786B2 (no)
DE (1) DE3780015T2 (no)
DK (1) DK613687A (no)
ES (1) ES2051723T3 (no)
FI (1) FI875145A (no)
GR (1) GR3005461T3 (no)
IL (1) IL84564A (no)
NO (1) NO167863C (no)
NZ (1) NZ222640A (no)
PH (1) PH25317A (no)
PT (1) PT86197B (no)
ZA (1) ZA878763B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851536A (en) * 1987-05-07 1989-07-25 American Home Products Corporation Cyclohexylquinolines as inhibitors of interleukin 1
US5202440A (en) * 1987-10-05 1993-04-13 Pfizer Inc. Certain 9-amino-2-(or 4)-oxa 1,2,3,4-tetrahydro- or 1,2,3,4,5,6,7,8-octahydro-acridines
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives
US5008853A (en) 1987-12-02 1991-04-16 Xerox Corporation Representation of collaborative multi-user activities relative to shared structured data objects in a networked workstation environment
US4985430A (en) 1987-12-03 1991-01-15 Mitsubishi Kasei Corporation 9-acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
CA2029497C (en) * 1989-11-08 2002-06-04 Kunihiro Ninomiya (Deceased) 4-acylaminopyridine derivative
US5608067A (en) * 1993-12-09 1997-03-04 Afonso; Adriano 4-substituted pyrazoloquinoline derivatives
US5786480A (en) * 1994-04-28 1998-07-28 Schering Corporation 4-substituted pyrazoloquinoline derivatives
KR101953366B1 (ko) 2018-12-26 2019-02-28 정종문 침향을 포함하는 기억력 및 인지능력을 향상시키는 기능성 건강식품 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8329531D0 (en) * 1983-11-04 1983-12-07 Ici America Inc Pyrazolopyridine cycloalkanones
ATE63903T1 (de) * 1984-10-25 1991-06-15 Hoechst Roussel Pharma 9-amino-1,2,3,4-tetrahydroacridin-1-ol und verwandte verbindungen, verfahren zu ihrer herstellung und verwendung als arzneimittel.
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives

Also Published As

Publication number Publication date
GR3005461T3 (no) 1993-05-24
FI875145A (fi) 1988-05-25
US4753950A (en) 1988-06-28
DE3780015D1 (de) 1992-07-30
ES2051723T3 (es) 1994-07-01
NO874872D0 (no) 1987-11-23
DK613687D0 (da) 1987-11-23
KR880006203A (ko) 1988-07-22
FI875145A0 (fi) 1987-11-20
IL84564A0 (en) 1988-04-29
NO167863C (no) 1991-12-18
PT86197A (en) 1987-12-01
AU604786B2 (en) 1991-01-03
DE3780015T2 (de) 1993-01-21
ZA878763B (en) 1988-05-19
IL84564A (en) 1993-03-15
EP0273176A2 (en) 1988-07-06
PT86197B (pt) 1990-11-07
NO874872L (no) 1988-05-25
ATE77625T1 (de) 1992-07-15
NO167863B (no) 1991-09-09
DK613687A (da) 1988-05-25
AU8148387A (en) 1988-05-26
NZ222640A (en) 1990-10-26
JPS63141980A (ja) 1988-06-14
EP0273176A3 (en) 1988-07-20
EP0273176B1 (en) 1992-06-24

Similar Documents

Publication Publication Date Title
PH25571A (en) Alpha'-alkyl-4-amino-3-quinolinemethanols, 1-(4-aralkylamino-3-quinolinyl) alaknones, their use as medicaments
IL96209A0 (en) 4-and 6-carbamates related to physostigmine,a process for their preparation and their use as medicaments
PH25317A (en) FUSED THIENO-, PYRAZOLO- or FURANS-TETRAHYDROAMINO-QUINOLINOLS, AMINOTETRAHYDROBENZONAPHTHYRIDINES, THEIR USE AS MEDICAMENTS
HU912786D0 (en) Process for producing 4-substituted-dihydro-pyrido(4,3-d) pyrimidine derivatives as well as pharmaceutical preparatives containing said compounds
ZA898498B (en) 1,2,3,4-tetrahydro-1,9-acridinediamines,a process for their preparation and their use as medicaments
ES2064533T3 (es) Acido(1,2,3,4-tetrahidro-9-acridinimino)-ciclohexanocarboxilico y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos.
IE902078L (en) 4,5,5a,6-Tetrahydro-3H-isoxazolo£5,4,3-k1|acridines¹derivatives, a process for their preparation and their use¹as medicaments
PT82187B (en) Benzo<c>-1,5-naphthyridines a process and intermediates for their preparation and their use as medicaments